Efficacy and Safety of Ocudox Lid Wipes Compared to Traditional Lid Cleaning
Comparison in the Efficiency and Safety Between the Applications of New Hypochlorous Acid Eyelid Wipes and Povidone Lodine on the Eye Surface
2 other identifiers
interventional
7
1 country
1
Brief Summary
The use of povidone iodine solution for prophylaxis of endophthalmitis is well established for intraocular procedures like cataract surgery and for injections of anti-VEGF agents for retinal diseases such as age-related macular degeneration. Unfortunately iodine is unfriendly to the ocular surface, and when repeated often enough (some patients require up to monthly injections of anti-VEGF agents for the entire year), corneal epitheliopathy and secondary dry eye results. Unfortunately, there is no good alternative to cleaning patient's eyelid at the moment. Ocudox is a relatively new antibacterial product (spraying on eyelid wipe) which contains Neutrox (pure hypochlorous acid) that kills many microbes, but remain very friendly and non-toxic for the ocular surface.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Oct 2018
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 3, 2018
CompletedFirst Posted
Study publicly available on registry
December 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedMay 13, 2019
December 1, 2018
6 months
December 3, 2018
May 9, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
SPEED Questionnaire
To compare the frequency and severity of dry eye symptoms at baseline and after 21 days
21 days
Study Arms (2)
Ocudox lid wiped
EXPERIMENTALPovidone Iodine
ACTIVE COMPARATORInterventions
This is a pure hypochlorous acid that kills many microbes, but remain very friendly and non-toxic for the ocular surface.
Eligibility Criteria
You may qualify if:
- Participants must be 50 to 60 years old with Meibomian Gland Dysfunction (MGD)
You may not qualify if:
- Willing to perform all eye examinations in this study
- Participants diagnosed with diabetes
- No recent eye surgery or eye procedure within 1 month
- Participants who are unsuitable for Oculus K5M recording such as musculoskeletal problems
- Participants who are unable to tolerate Oculus K5M recording machine
- Is pregnant, lactating or planning a pregnancy
- Any other specified reason as determined by clinical investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Singapore Eye Research Institute
Singapore, 169856, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louis Tong, PhD
Singapore Eye Research Institute
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- Investigator will be masked
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinician-Scientist, Senior Consultant
Study Record Dates
First Submitted
December 3, 2018
First Posted
December 4, 2018
Study Start
October 1, 2018
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
May 13, 2019
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share